Gluetacs Therapeutics was successfully approved for the “2025 Lingang Special Area Patent Navigation Project.”

ON：2025-09-04 TAGS：GLUETACS THERAPEUTICS

Recently, the Market Supervision Administration of Lingang Special Area organized the application process for the 2025 Patent Navigation Project. After multiple stages, including voluntary applications by innovative entities, document review, and expert evaluation, Gluetacs Therapeutics was successfully approved for the “2025 Lingang Special Area Patent Navigation Project.” This achievement represents an authoritative recognition of the company’s innovative capabilities and intellectual property management expertise, marking a new milestone in enhancing patent quality and strategic core technology layout.

Patent navigation is an advanced patent information application model that integrates patent data with various other data resources to support macro-level decision-making, industrial planning, corporate operations, and innovation activities. It provides a panoramic analysis of regional development positioning, industrial competition landscape, corporate strategic decisions, and technological innovation directions, thereby facilitating the effective allocation of resources and improving the precision and scientific rigor of decision-making.